Prime Medicine stock soars amid gene editing sector momentum
Go back to Prime Medicine stock soars amid gene editing sector momentum| AbbVie (NYSE: ABBV) | Delayed: 260.21 -1.51 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $261.72 | 52 Week High | $68.12 | |||
| Open | $264.00 | 52 Week Low | $50.71 | |||
| Day High | $264.25 | P/E | 56.44 | |||
| Day Low | $257.14 | EPS | $4.61 | |||
| Volume | 2,878,596 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1159.60 -0.48 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1160.08 | 52 Week High | $88.16 | |||
| Open | $1170.00 | 52 Week Low | $67.88 | |||
| Day High | $1171.66 | P/E | 268.43 | |||
| Day Low | $1137.50 | EPS | $4.32 | |||
| Volume | 2,552,803 | |||||
| (NASDAQ: PRME) | Delayed: 3.71 +0.04 (1.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.67 | 52 Week High | $21.72 | |||
| Open | $3.70 | 52 Week Low | $18.36 | |||
| Day High | $3.72 | P/E | N/A | |||
| Day Low | $3.49 | EPS | $0.00 | |||
| Volume | 2,312,466 | |||||
| (NASDAQ: VERV) | Delayed: 11.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.13 | 52 Week High | $ | |||
| Open | $11.13 | 52 Week Low | $ | |||
| Day High | $11.13 | P/E | N/A | |||
| Day Low | $11.13 | EPS | $ | |||
| Volume | 56,718 | |||||

